Personal History:

Dr. Iacono recently joined the University of Maryland faculty from University of Pittsburgh School of Medicine where he served as Medical Director of Lung Transplantation. Dr. Iacono has established a national reputation as an outstanding transplant pulmonologist and a translational investigator focusing on novel anti-rejection therapy. He has been a leader in developing aerosolized antirejection therapy to reduce the incidence of chronic lung transplant rejection and minimize systemic side effects of antirejection medications.

Research Interests:

Complications of lung transplantiation

Markers of lung transplant rejection

Novel anti-rejection therapies

Aerosolized anti-rejection therapy for lung transplant patients

Patents, Inventions, Copyrights:

US patent application, November 11,1999: A32130-072396.0162 by Iacono et.al: “Uses of aerosol cyclosporine for prevention and treatment of pulmonary disease”